A detailed analysis of Acquired Immunodeficiency Syndrome Market Size, Growth Opportunities, Emerging Therapies, and Epidemiology Forecast


Acquired Immunodeficiency Syndrome (AIDS) is the most severe stage of HIV infection when a person’s CD4 cell count \sdrops below 200 cells/mm and the person’s immune system is no longer able to regulate viral infection. The Human Immunodeficiency Virus is what causes AIDS (HIV). Sexual contact, blood transfusions, sharing of intravenous needles, and during childbirth and breastfeeding, from the mother to the kid. Phases of the HIV illness are distinct: viral asymptomatic chronic transmission, abrupt seroconversion, acute retroviral syndrome, recovery, and seroconversion. 

HIV viral load reduction, monitoring, and opportunistic sickness or condition are the main goals of AIDS treatment. VOCABRIA (Cabotegravir) is a human antiretroviral drug used to increase CD4 cells during antiretroviral therapy (ART). Integrase strand transfer inhibitor for the HIV-1 infection. The sector of medications with many classes retains the biggest market share since it uses the most cutting-edge method for treating HIV infection. Due to their improved outcomes in the management of HIV & related diseases, this is also ascribed to an increase in adoption. Co-infections and how easily they can be consumed and adhered to. 

DelveInsight’s “Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the Acquired Immunodeficiency Syndrome Market Report: 

  • The prevalence of HIV/AIDS has increased over recent years with advancements in treatment allowing patients to live longer with HIV 

  • Nonetheless, the United States leads the market with a major share, by geography among the 7MM countries 

  • Despite our major successes in scaling up treatment and ongoing awareness, in the 7MM countries, there are still >35Million people living with HIV 

  • At year-end 2019, an estimated 1.2 million people in the United States aged 13 and older had HIV

Request a sample for the Report: https://www.delveinsight.com/sample-request/acquired-immunodeficiency-syndrome-aids-market

Acquired Immunodeficiency Syndrome Symptoms:

The symptoms of Acquired Immunodeficiency Syndrome include –

  • Fever

  • Headaches

  • Muscle aches

  • Skin Rashes

  • Diarrhea

  • Abrupt weight loss

  • Sore throat and painful mouth sores

Acquired Immunodeficiency Syndrome Market  

The dynamics of the Acquired Immunodeficiency Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as COBI, maraviroc, and others during the forecasted period 2019-2032. 

Learn more by requesting for sample @Acquired Immunodeficiency Syndrome Market Landscape 

Acquired Immunodeficiency Syndrome Pipeline Therapies:

  • COBI

  • DRV

  • maraviroc

  • Ritonavir 

Acquired Immunodeficiency Syndrome Pipeline Key Companies:

  • Pfizer

  • Gilead Sciences

  • ViiV Healthcare

  • Aelix Therapeutics

Click here to read more about Acquired Immunodeficiency Syndrome Market Outlook 2032 

Related Reports: 

Acquired Immunodeficiency Syndrome Pipeline  

"Acquired Immunodeficiency Syndrome Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Acquired Immunodeficiency Syndrome market. A detailed picture of the Acquired Immunodeficiency Syndrome pipeline landscape is provided, which includes the disease overview and Acquired Immunodeficiency Syndrome treatment guidelines. 

Acquired Immunodeficiency Syndrome Epidemiology 

DelveInsight's 'Acquired Immunodeficiency Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Acquired Immunodeficiency Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

 

Diagnostic Imaging Equipment Market

 

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.

 

Invasive Candidiasis Market

 

"DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.

 

Sialidosis Market 

 

DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Filgrastim Biosimilar Insight

 

DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

 

Pain Management Devices Market

 

Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 

Latest Reports by DelveInsight


NCFB Market | Metastatic Bone Pain Market | Ventricular Hypertrophy Market | Diagnostic Imaging Equipment Market | Invasive Candidiasis Market | Upper Limb Hypertonia Market | Sialidosis Market | Filgrastim Biosimilar Insight | 3D Cardiac Mapping System Market | Acanthamoeba Keratitis Market | Adult Growth Hormone Deficiency Market | Advanced Cancer Pain Management Market | Apheresis Market | Arteriovenous fistula Market | Automated external defibrillators (AEDs) Market | Balloon Catheters Market | Calciphylaxis Market | Cerebral Aneurysm Market | Chronic Idiopathic Urticaria Market


To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services


Also, take a glance at the Blogs by DelveInsight:


 

Comments

Post a Comment

Popular posts from this blog

The Science Behind Vaccine Adjuvants: Strengthening Our Defenses

Image
  What are Vaccine Adjuvants? Vaccine adjuvants are substances added to vaccines to enhance the body’s immune response to the provided antigen. By boosting the efficacy of vaccines, adjuvants play a crucial role in providing long-lasting immunity against infectious diseases. They can help reduce the amount of antigen needed, thereby improving vaccine stability and cost-effectiveness. Types of Vaccine Adjuvants There are several types of vaccine adjuvants , each working through different mechanisms. Traditional adjuvants include aluminum salts (alum), which have been used for decades. Modern adjuvants include oil-in-water emulsions, liposomes, and saponins. Recent advancements have introduced TLR (Toll-like receptor) agonists, which stimulate specific immune pathways to enhance the vaccine's effectiveness. These include TLR3, TLR4, and TLR9 agonists, which mimic natural infection signals to elicit a stronger immune response. Vaccine Adjuvants Market Dynamics The global vaccine adju
Read more

FDA Approval Marks New Hope: Eli Lilly’s Donanemab for Alzheimer’s Disease

Image
  The Birth of a Breakthrough Eli Lilly’s groundbreaking drug, Donanemab, has recently received FDA approval, marking a significant milestone in Alzheimer’s disease treatment . This innovative therapy, designed to target and reduce amyloid plaques in the brain, offers new hope for patients battling this debilitating condition. Donanemab’s approval comes at a pivotal moment, as it represents a major advancement in the Alzheimer’s disease pipeline, promising improved outcomes for those affected. Navigating Regulatory Waters The journey of Donanemab through the regulatory landscape was complex, characterized by rigorous scrutiny and extensive clinical trials. Eli Lilly’s success in obtaining FDA approval highlights the drug’s potential to revolutionize Alzheimer’s disease therapies . This regulatory endorsement not only underscores the efficacy and safety of Donanemab but also sets a new standard for the evaluation of future treatments. Donanemab: Cost and Coverage As with many groundbre
Read more

Papilloma Market Report: Detailed Epidemiology and 2032 Forecast

Image
Papilloma is a benign tumor that arises from epithelial tissue and is often associated with the human papillomavirus (HPV). These tumors can occur in various body parts, including the skin, mucous membranes, and genital areas. Understanding the market dynamics, epidemiology, and future trends for papilloma is crucial for developing effective treatments and improving patient outcomes. Papilloma Market Insight The papilloma market is experiencing steady growth, driven by increasing awareness of HPV-related diseases and advancements in diagnostic technologies. Papilloma can lead to complications if left untreated, making early diagnosis and effective treatment essential. The market for papilloma therapies includes a range of options such as antiviral drugs, cryotherapy, and surgical interventions. The introduction of novel therapies and ongoing research into targeted treatments are expected to enhance patient outcomes and drive market growth. Papilloma Epidemiology Papilloma is relative
Read more